胰腺癌放射治疗100418讲解材料.pptVIP

胰腺癌放射治疗 ;胰腺癌治疗结果现状;;;;;;;;外科治疗胰腺癌结论;手术治疗经验与放疗-影响放疗前途;胰十二指肠切除术治疗胰头癌切除的范围：;保持手术多样化—争鸣的基础;手术治疗失败原因的探讨;淋巴结转移与生存;;淋巴结转移与生存率;淋巴结转移病理检测阳性率的影响因素;淋巴结转移病理检测阳性率的影响因素;术后肝转移;;胰腺放疗方式;胰腺癌放射治疗照射剂量限制因素（1）;胰腺癌放射治疗照射剂量限制因素（2）;放射治疗靶区的确认;;A. Saleem et al. Radiotherapy in the Management of Unresectable Locally Advanced Pancreatic Cancer: a Survey of the Current UK Practice of Clinical Oncologists . Clinical Oncology 2010 ;;;;;胰腺癌术中放疗;;Vincenzo et.al, Intra-operative radiotherapy (IORT) in pancreatic cancer: Joint analysis of the ISIORT-Europe experience 。Radiotherapy and Oncology Volume 91, Issue 1, April 2009, Pages 54-59 ;A 局控率 B 生存率;手术切除方式、肿瘤大小与局部控制率;手术+术后同期放化疗;手术+术后同期放化疗;;;;胰腺癌SBRT;;;胰腺癌SBRT治疗结果;Stereotactic Body Radiation Therapy Boost in Locally Advanced Pancreatic Cancer  YoungSeok Seo M.D et al;常规分割放疗+SBRT;治疗结果;治疗毒性;进展期胰腺癌同步放化疗;进展期胰腺癌同步放化疗;Pin-I. Huang et al. Efficacy and Factors Affecting Outcome of Gemcitabine Concurrent Chemoradiotherapy in Patients With Locally Advanced Pancreatic Cancer . International Journal of Radiation Oncology*Biology*PhysicsVolume 73, Issue 1, 1 January 2009, Pages 159-165 ;健择增敏机制：;;;健择增敏毒性：;;;External Beam Radiotherapy Plus 24-Hour Continuous Infusion of Gemcitabine in Unresectable Pancreatic Carcinoma: Long-Term Results of a Phase II Study  Gian C. et al;治疗毒性;治疗结果;每周两次GEM同期放疗临床研究;同期放化疗中健择应用剂量的研究;放化疗与分子靶向治疗：;